Isda’s Korean OTC law criticism
South Korea’s New Product Approval bill passed its first stage on February 16. The bill has been strongly opposed by Isda. Here are its concerns in full
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: